Pub Date : 2025-08-22eCollection Date: 2025-01-01DOI: 10.1177/20503121251336046
Thejas Marike Shivakumar, Nitika C Panakkal, Shailesh Nayak, Rajagopal Kadavigere, Tanushree R Kamath, Suresh Sukumar
Objectives: Radiation exposure has been a cause of concern in computed tomography imaging. Reducing radiation dose increases the image noise which can be compensated by using reconstruction techniques. Recently artificial intelligence-based reconstruction technique has been introduced. Therefore, the purpose of the study was to prospectively compare the image quality between Idose4 and Precise Image in normal BMI individuals.
Methods: Sixty-six consecutive patients with a normal body habitus undergoing contrast-enhanced abdomen and pelvis scan were included in the study. All scans were performed using 100 kVp and tube current modulation. The acquired images were reconstructed to iDose4 and precise imaging. Quantitatively images were analyzed by placing regions of interest in different organs to estimate the image noise, signal-to-noise ratio, and contrast-to-noise ratio. Qualitative analysis was done by two radiologists on a five-point Likert scale.
Results: Image noise was significantly reduced using Precise Image across the plain (9.11 ± 1.43 vs 8.18 ± 1.2), arterial (14.34 ± 2.1 vs 10.21 ± 1.5), and portovenous phase (14.78 ± 2.30 vs 11.97 ± 2.07) with maximum noise reduction in the arterial and portovenous phases. Signal-to-noise ratio and contrast-to-noise ratio was significantly improved in all the organs across the plain, arterial, and portovenous phases. Qualitative analysis showed no significant difference between Idose4 and Precise Image with regards to visualization of large vessels in the arterial and portovenous phases. However, precise image was graded better than Idose4 with respect to visualization/conspicuity, image noise, and artifacts.
Conclusion: Precise Image can be useful in reducing the image noise and improving the signal-to-noise ratio and contrast-to-noise ratio in low-dose computed tomography protocol among normal BMI individuals.
目的:在计算机断层成像中,辐射暴露一直是一个值得关注的问题。降低辐射剂量会增加图像噪声,而图像噪声可以通过重建技术加以补偿。近年来引入了基于人工智能的重建技术。因此,本研究的目的是前瞻性地比较Idose4和Precise image在BMI正常个体中的图像质量。方法:连续66例身体体质正常的患者行腹部和骨盆增强扫描。所有扫描均使用100 kVp和管电流调制进行。将采集到的图像重构为iDose4并进行精密成像。通过在不同器官上放置感兴趣的区域来定量分析图像,以估计图像的噪声、信噪比和对比噪比。定性分析是由两名放射科医生按照李克特五分制进行的。结果:采用精确成像技术可明显降低平原期(9.11±1.43 vs 8.18±1.2)、动脉期(14.34±2.1 vs 10.21±1.5)和门静脉期(14.78±2.30 vs 11.97±2.07)的图像噪声,其中动脉期和门静脉期降噪最大。平、动脉、门静脉期各脏器的信噪比和信噪比均有明显改善。定性分析显示,Idose4与Precise Image在动脉和门静脉期大血管的显示方面无显著差异。然而,在可视化/显著性、图像噪声和伪影方面,精确图像的评分优于Idose4。结论:在BMI正常人群的低剂量计算机断层扫描中,精确成像有助于降低图像噪声,提高信噪比和对比噪比。
{"title":"A comparison of the image quality between deep learning reconstruction algorithm and iDose4 using low dose abdominopelvic computed tomography for individuals with normal BMI.","authors":"Thejas Marike Shivakumar, Nitika C Panakkal, Shailesh Nayak, Rajagopal Kadavigere, Tanushree R Kamath, Suresh Sukumar","doi":"10.1177/20503121251336046","DOIUrl":"10.1177/20503121251336046","url":null,"abstract":"<p><strong>Objectives: </strong>Radiation exposure has been a cause of concern in computed tomography imaging. Reducing radiation dose increases the image noise which can be compensated by using reconstruction techniques. Recently artificial intelligence-based reconstruction technique has been introduced. Therefore, the purpose of the study was to prospectively compare the image quality between Idose4 and Precise Image in normal BMI individuals.</p><p><strong>Methods: </strong>Sixty-six consecutive patients with a normal body habitus undergoing contrast-enhanced abdomen and pelvis scan were included in the study. All scans were performed using 100 kVp and tube current modulation. The acquired images were reconstructed to iDose4 and precise imaging. Quantitatively images were analyzed by placing regions of interest in different organs to estimate the image noise, signal-to-noise ratio, and contrast-to-noise ratio. Qualitative analysis was done by two radiologists on a five-point Likert scale.</p><p><strong>Results: </strong>Image noise was significantly reduced using Precise Image across the plain (9.11 ± 1.43 vs 8.18 ± 1.2), arterial (14.34 ± 2.1 vs 10.21 ± 1.5), and portovenous phase (14.78 ± 2.30 vs 11.97 ± 2.07) with maximum noise reduction in the arterial and portovenous phases. Signal-to-noise ratio and contrast-to-noise ratio was significantly improved in all the organs across the plain, arterial, and portovenous phases. Qualitative analysis showed no significant difference between Idose4 and Precise Image with regards to visualization of large vessels in the arterial and portovenous phases. However, precise image was graded better than Idose4 with respect to visualization/conspicuity, image noise, and artifacts.</p><p><strong>Conclusion: </strong>Precise Image can be useful in reducing the image noise and improving the signal-to-noise ratio and contrast-to-noise ratio in low-dose computed tomography protocol among normal BMI individuals.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"13 ","pages":"20503121251336046"},"PeriodicalIF":2.1,"publicationDate":"2025-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12374083/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144966903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Cytomegalovirus infection is a common complication following hematopoietic stem cell transplantation that significantly influences clinical outcomes.
Objectives: To develop and validate a predictive model for cytomegalovirus infection risk in patients with β-thalassemia major undergoing hematopoietic stem cell transplantation.
Design: Retrospective cohort study.
Methods: Clinical data from 291 β-thalassemia major patients undergoing hematopoietic stem cell transplantation were retrospectively analyzed. Independent risk factors identified via univariate and multivariate logistic regression analyses formed the basis of a predictive nomogram. The model's performance was evaluated by the concordance index (C-index), receiver operating characteristic curves, calibration plots, and decision curve analysis. Internal validation was performed using bootstrap resampling, and external validation was conducted with an independent cohort of 84 patients from another center.
Results: Three independent predictors of cytomegalovirus infection were identified: serum albumin levels, donor type, and grade III-IV acute graft-versus-host disease. A nomogram incorporating these predictors was established, demonstrating good discriminative ability (C-index: 0.745; 95% CI: 0.684-0.807). Internal and external validations yielded C-indices of 0.746 and 0.649, respectively. Receiver operating characteristic analysis showed an area under the curve of 0.745 in the training cohort and 0.649 in the validation cohort.
Conclusion: We developed and validated a reliable predictive model for assessing cytomegalovirus infection risk after hematopoietic stem cell transplantation in β-thalassemia major patients. This scoring system offers clinicians a practical tool for early risk stratification and intervention.
{"title":"Prediction model for cytomegalovirus infection following hematopoietic stem cell transplantation in patients with β-thalassemia major.","authors":"Lin Pan, Zhenbin Wei, Yanni Xie, Zhaoping Gan, Hongwen Xiao, Lianjin Liu, Lingling Shi, Zhongming Zhang, Meiqing Wu, Yinghua Chen, Yanye Liu, Xuemei Zhou, Chan Li, Chunjie Qin, Yongrong Lai, Rongrong Liu","doi":"10.1177/20503121251360132","DOIUrl":"10.1177/20503121251360132","url":null,"abstract":"<p><strong>Background: </strong>Cytomegalovirus infection is a common complication following hematopoietic stem cell transplantation that significantly influences clinical outcomes.</p><p><strong>Objectives: </strong>To develop and validate a predictive model for cytomegalovirus infection risk in patients with β-thalassemia major undergoing hematopoietic stem cell transplantation.</p><p><strong>Design: </strong>Retrospective cohort study.</p><p><strong>Methods: </strong>Clinical data from 291 β-thalassemia major patients undergoing hematopoietic stem cell transplantation were retrospectively analyzed. Independent risk factors identified via univariate and multivariate logistic regression analyses formed the basis of a predictive nomogram. The model's performance was evaluated by the concordance index (C-index), receiver operating characteristic curves, calibration plots, and decision curve analysis. Internal validation was performed using bootstrap resampling, and external validation was conducted with an independent cohort of 84 patients from another center.</p><p><strong>Results: </strong>Three independent predictors of cytomegalovirus infection were identified: serum albumin levels, donor type, and grade III-IV acute graft-versus-host disease. A nomogram incorporating these predictors was established, demonstrating good discriminative ability (C-index: 0.745; 95% CI: 0.684-0.807). Internal and external validations yielded C-indices of 0.746 and 0.649, respectively. Receiver operating characteristic analysis showed an area under the curve of 0.745 in the training cohort and 0.649 in the validation cohort.</p><p><strong>Conclusion: </strong>We developed and validated a reliable predictive model for assessing cytomegalovirus infection risk after hematopoietic stem cell transplantation in β-thalassemia major patients. This scoring system offers clinicians a practical tool for early risk stratification and intervention.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"13 ","pages":"20503121251360132"},"PeriodicalIF":2.1,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12314255/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144776160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-29eCollection Date: 2025-01-01DOI: 10.1177/20503121251360176
Kai Zhang, Hongqiang Wang, Chuang Wang, Runze Liu, Xinge Shi, Weiran Hu
Objectives: Previous studies reported that many inflammatory factors have associations with osteoporosis. This study use Mendelian randomization (MR) analysis to explore the causal genetic relationship between 41 inflammatory factors and osteoporosis.
Methods: A bidirectional two-sample MR analysis was performed by employing five Mendelian randomization analysis methods including MR Egger regression, weighted median, inverse-variance weighted and weight mode methods. Summary statistics from the genome-wide association study (GWAS) of 41 inflammatory cytokines and osteoporosis were included in this study. This study examined the MR analysis results for heterogeneity and horizontal pleiotropy.
Results: Using the inverse variance weighted (IVW) method, this analysis indicated that elevated monocyte chemotactic protein-1 (MCP-1) levels were potentially linked to a 22% increased likelihood of osteoporosis (Odds Ratio (OR) = 1.22, 95% CI: 1.04-1.43, p = 0.014). Additionally, through the IVW approach, we observed that higher tumor necrosis factor-related apoptosis inducing ligand (TRAIL) levels were possibly associated with a 15% greater risk of osteoporosis (OR = 1.12, 95% CI: 1.03-1.29, p = 0.012). Other 39 inflammatory cytokines don't have casual genetic association with osteoporosis. When this study use MR to estimate the influence of osteoporosis on inflammatory factors, none of the p-values with IVW method were lower than 0.05.
Conclusion: This is the first bidirectional MR analysis to explore the causal genetic relationship between inflammatory cytokines and osteoporosis. This study found that MCP-1 and TRAIL are probably the upstream factors correlated with osteoporosis, and no inflammatory cytokine was involved in osteoporosis development downstream.
目的:以往的研究报道了许多炎症因子与骨质疏松症有关。本研究采用孟德尔随机化(MR)分析探讨41种炎症因子与骨质疏松症的因果遗传关系。方法:采用MR Egger回归、加权中位数法、反方差加权法、权模法等5种孟德尔随机化分析方法进行双向双样本MR分析。本研究纳入了41种炎症细胞因子与骨质疏松症的全基因组关联研究(GWAS)的汇总统计数据。本研究检验了MR分析结果的异质性和水平多效性。结果:使用逆方差加权(IVW)方法,该分析表明单核细胞趋化蛋白-1 (MCP-1)水平升高可能与骨质疏松症的可能性增加22%有关(优势比(OR) = 1.22, 95% CI: 1.04-1.43, p = 0.014)。此外,通过IVW方法,我们观察到较高的肿瘤坏死因子相关凋亡诱导配体(TRAIL)水平可能与骨质疏松症风险增加15%相关(OR = 1.12, 95% CI: 1.03-1.29, p = 0.012)。其他39种炎性细胞因子与骨质疏松症没有偶然的遗传关联。本研究用MR估计骨质疏松对炎症因子的影响时,IVW法的p值均不低于0.05。结论:这是首次双向MR分析探讨炎症细胞因子与骨质疏松症之间的因果遗传关系。本研究发现MCP-1和TRAIL可能是与骨质疏松相关的上游因素,而下游没有炎症细胞因子参与骨质疏松的发生。
{"title":"Exploring the causal genetic relationship between 41 inflammatory cytokines and osteoporosis: a bidirectional Mendelian randomization analysis.","authors":"Kai Zhang, Hongqiang Wang, Chuang Wang, Runze Liu, Xinge Shi, Weiran Hu","doi":"10.1177/20503121251360176","DOIUrl":"10.1177/20503121251360176","url":null,"abstract":"<p><strong>Objectives: </strong>Previous studies reported that many inflammatory factors have associations with osteoporosis. This study use Mendelian randomization (MR) analysis to explore the causal genetic relationship between 41 inflammatory factors and osteoporosis.</p><p><strong>Methods: </strong>A bidirectional two-sample MR analysis was performed by employing five Mendelian randomization analysis methods including MR Egger regression, weighted median, inverse-variance weighted and weight mode methods. Summary statistics from the genome-wide association study (GWAS) of 41 inflammatory cytokines and osteoporosis were included in this study. This study examined the MR analysis results for heterogeneity and horizontal pleiotropy.</p><p><strong>Results: </strong>Using the inverse variance weighted (IVW) method, this analysis indicated that elevated monocyte chemotactic protein-1 (MCP-1) levels were potentially linked to a 22% increased likelihood of osteoporosis (Odds Ratio (OR) = 1.22, 95% CI: 1.04-1.43, <i>p</i> = 0.014). Additionally, through the IVW approach, we observed that higher tumor necrosis factor-related apoptosis inducing ligand (TRAIL) levels were possibly associated with a 15% greater risk of osteoporosis (OR = 1.12, 95% CI: 1.03-1.29, <i>p</i> = 0.012). Other 39 inflammatory cytokines don't have casual genetic association with osteoporosis. When this study use MR to estimate the influence of osteoporosis on inflammatory factors, none of the p-values with IVW method were lower than 0.05.</p><p><strong>Conclusion: </strong>This is the first bidirectional MR analysis to explore the causal genetic relationship between inflammatory cytokines and osteoporosis. This study found that MCP-1 and TRAIL are probably the upstream factors correlated with osteoporosis, and no inflammatory cytokine was involved in osteoporosis development downstream.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"13 ","pages":"20503121251360176"},"PeriodicalIF":2.1,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12314258/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144776147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Immune checkpoint inhibitors therapy in cancer patients may induce immune-related diabetes mellitus through islet β-cell destruction, necessitating systematic glycemic management. This scoping review aims to identify and synthesize evidence on glycemic management strategies for immune-related diabetes mellitus. Guided by Arksey and O'Malley's five-stage scoping review framework, we strictly adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews checklist. A systematic search was conducted across guideline repositories, academic databases, and professional oncology/endocrinology association websites. The search period spanned from database inception to June 30, 2024. Of 5085 initially identified records, 9 studies met inclusion criteria. Evidence was synthesized into five key domains: (1) risk assessment and early detection, (2) therapeutic interventions and monitoring, (3) patient education, (4) glycemic target optimization, and (5) multidisciplinary care coordination. This review consolidates evidence-based best practices for immune-related diabetes mellitus management derived from rigorous methodology. Clinicians should tailor these strategies to individual patient profiles to optimize outcomes while mitigating treatment disruptions.
{"title":"Glycemic management in patients with immune-related diabetes mellitus: A scoping review.","authors":"Yuan Jiang, Xiaoyan Wang, Lei Lei, Lihua Liu, Danfeng Wu, Siqi Zhang, Dairong Tang, Lingli Fan, Zhou Wen, Xiaojing Xue, Gang Feng","doi":"10.1177/20503121251358313","DOIUrl":"10.1177/20503121251358313","url":null,"abstract":"<p><p>Immune checkpoint inhibitors therapy in cancer patients may induce immune-related diabetes mellitus through islet β-cell destruction, necessitating systematic glycemic management. This scoping review aims to identify and synthesize evidence on glycemic management strategies for immune-related diabetes mellitus. Guided by Arksey and O'Malley's five-stage scoping review framework, we strictly adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews checklist. A systematic search was conducted across guideline repositories, academic databases, and professional oncology/endocrinology association websites. The search period spanned from database inception to June 30, 2024. Of 5085 initially identified records, 9 studies met inclusion criteria. Evidence was synthesized into five key domains: (1) risk assessment and early detection, (2) therapeutic interventions and monitoring, (3) patient education, (4) glycemic target optimization, and (5) multidisciplinary care coordination. This review consolidates evidence-based best practices for immune-related diabetes mellitus management derived from rigorous methodology. Clinicians should tailor these strategies to individual patient profiles to optimize outcomes while mitigating treatment disruptions.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"13 ","pages":"20503121251358313"},"PeriodicalIF":2.1,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12314252/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144776159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Evidence-based practice in intrapartum care is critical for lowering maternal and neonatal mortality and morbidity. Evidence-based practice, according to the World Health Organization Quality of Care Framework for Maternal and Newborn Health, is an important component of intrapartum care. However, little is understood about evidence-based intrapartum care practice in Ethiopia, particularly in the study setting.
Objective: To assess evidence-based intrapartum care practice and associated factors among obstetric care professionals in Jimma Zone public hospitals in Southwest Ethiopia.
Methods: A facility-based cross-sectional study was carried out on 217 obstetric care providers in Jimma Zone public hospitals in southwest Ethiopia. The study used a census approach to include all eligible participants within the specified population. Data were collected from June 1 to 30, 2023, using semistructured self-administered questionnaires. The collected data were entered into EpiData version 4.6 and exported to Statistical Packages for Social Sciences version 25 for analysis. Multivariable logistic regression was run to see the association between evidence-based intrapartum care practice and predictor variables. Statistical significance was set at p-values less than 0.05 in the multivariable logistic regression.
Results: Overall, 41.2% (95% CI: 40.8-42.3) of obstetric care providers in Jimma Zone public hospitals used evidence-based practices for intrapartum care. Attending in-service training (AOR (95% CI): 3.5 (1.61-9.71)), accessibility of obstetric care guidelines (AOR (95% CI): 2.082 (1.222-3.547)), having regular case presentation (AOR (95% CI): 2.5 (1.234-6.743)), having knowledge (AOR (95% CI): 2.3 (1.222-3.547)), attitude of obstetric care providers (AOR (95% CI): 1.847 (1.065-3.204)), having less than 2 years of work experience (AOR (95% CI): 1.32 (1.012-3.56)), and having 2-5 years of work experience (AOR (95% CI): 3.49 (1.23-6.312)) were among factors significantly associated with evidence-based intra-partum care practice of obstetric care providers in Jimma Zone public hospitals.
Conclusions: This study indicated that the majority of obstetric care providers did not practice evidence-based intrapartum care, which requires attention from all stakeholders. It is recommended for hospitals in the Jimma Zone to make guidelines available, provide in-service trainings, and identify systematic strategies to improve the knowledge and attitude of obstetric care providers.
{"title":"Evidence-based intrapartum care practice and associated factors among obstetric care providers in Jimma Zone public hospitals, southwest Ethiopia: A cross-sectional study.","authors":"Diriba Wakjira, Eneyew Melkamu Andualem, Azmeraw Bekele, Desalew Tilahun Beyene","doi":"10.1177/20503121251358969","DOIUrl":"10.1177/20503121251358969","url":null,"abstract":"<p><strong>Background: </strong>Evidence-based practice in intrapartum care is critical for lowering maternal and neonatal mortality and morbidity. Evidence-based practice, according to the World Health Organization Quality of Care Framework for Maternal and Newborn Health, is an important component of intrapartum care. However, little is understood about evidence-based intrapartum care practice in Ethiopia, particularly in the study setting.</p><p><strong>Objective: </strong>To assess evidence-based intrapartum care practice and associated factors among obstetric care professionals in Jimma Zone public hospitals in Southwest Ethiopia.</p><p><strong>Methods: </strong>A facility-based cross-sectional study was carried out on 217 obstetric care providers in Jimma Zone public hospitals in southwest Ethiopia. The study used a census approach to include all eligible participants within the specified population. Data were collected from June 1 to 30, 2023, using semistructured self-administered questionnaires. The collected data were entered into EpiData version 4.6 and exported to Statistical Packages for Social Sciences version 25 for analysis. Multivariable logistic regression was run to see the association between evidence-based intrapartum care practice and predictor variables. Statistical significance was set at <i>p</i>-values less than 0.05 in the multivariable logistic regression.</p><p><strong>Results: </strong>Overall, 41.2% (95% CI: 40.8-42.3) of obstetric care providers in Jimma Zone public hospitals used evidence-based practices for intrapartum care. Attending in-service training (AOR (95% CI): 3.5 (1.61-9.71)), accessibility of obstetric care guidelines (AOR (95% CI): 2.082 (1.222-3.547)), having regular case presentation (AOR (95% CI): 2.5 (1.234-6.743)), having knowledge (AOR (95% CI): 2.3 (1.222-3.547)), attitude of obstetric care providers (AOR (95% CI): 1.847 (1.065-3.204)), having less than 2 years of work experience (AOR (95% CI): 1.32 (1.012-3.56)), and having 2-5 years of work experience (AOR (95% CI): 3.49 (1.23-6.312)) were among factors significantly associated with evidence-based intra-partum care practice of obstetric care providers in Jimma Zone public hospitals.</p><p><strong>Conclusions: </strong>This study indicated that the majority of obstetric care providers did not practice evidence-based intrapartum care, which requires attention from all stakeholders. It is recommended for hospitals in the Jimma Zone to make guidelines available, provide in-service trainings, and identify systematic strategies to improve the knowledge and attitude of obstetric care providers.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"13 ","pages":"20503121251358969"},"PeriodicalIF":2.1,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12301604/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144733021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-24eCollection Date: 2025-01-01DOI: 10.1177/20503121251360090
Xiang Li, Zhen Liu, Lei Liu
Objective: To establish and validate a deep learning model that simultaneously segments pediatric burn wounds and grades burn depth under complex, real-world imaging conditions.
Methods: We retrospectively collected 4785 smartphone or camera photographs from hospitalized children over 5 years and annotated 14,355 burn regions as superficial second-degree, deep second-degree, or third-degree. Images were resized to 256 × 256 pixels and augmented by flipping and random rotation. A DeepLabv3 network with a ResNet101 backbone was enhanced with channel- and spatial attention modules, dropout-reinforced Atrous Spatial Pyramid Pooling, and a weighted cross-entropy loss to counter class imbalance. Ten-fold cross-validation (60 epochs, batch size 8) was performed using the Adam optimizer (learning rate 1 × 10⁻⁴).
Results: The proposed Deep Fusion Network (attention-enhanced DeepLabv3-ResNet101, Dfusion) model achieved a mean segmentation Dice coefficient of 0.8766 ± 0.012 and an intersection-over-union of 0.8052 ± 0.015. Classification results demonstrated an accuracy of 97.65%, precision of 88.26%, recall of 86.76%, and an F1-score of 85.33%. Receiver operating characteristic curve analysis yielded area under the curve values of 0.82 for superficial second-degree, 0.76 for deep second-degree, and 0.78 for third-degree burns. Compared with baseline DeepLabv3, FCN-ResNet101, U-Net-ResNet101, and MobileNet models, Dfusion improved Dice by 15.2%-19.7% and intersection-over-union by 14.9%-23.5% (all p < 0.01). Inference speed was 0.38 ± 0.03 s per image on an NVIDIA GTX 1060 GPU, highlighting the modest computational demands suitable for mobile deployment.
Conclusion: Dfusion provides accurate, end-to-end segmentation and depth grading of pediatric burn wounds captured in uncontrolled environments. Its robust performance and modest computational demand support deployment on mobile devices, offering rapid, objective assistance for clinicians in resource-limited settings and enabling more precise triage and treatment planning for pediatric burn care.
{"title":"Pediatric BurnNet: Robust multi-class segmentation and severity recognition under real-world imaging conditions.","authors":"Xiang Li, Zhen Liu, Lei Liu","doi":"10.1177/20503121251360090","DOIUrl":"10.1177/20503121251360090","url":null,"abstract":"<p><strong>Objective: </strong>To establish and validate a deep learning model that simultaneously segments pediatric burn wounds and grades burn depth under complex, real-world imaging conditions.</p><p><strong>Methods: </strong>We retrospectively collected 4785 smartphone or camera photographs from hospitalized children over 5 years and annotated 14,355 burn regions as superficial second-degree, deep second-degree, or third-degree. Images were resized to 256 × 256 pixels and augmented by flipping and random rotation. A DeepLabv3 network with a ResNet101 backbone was enhanced with channel- and spatial attention modules, dropout-reinforced Atrous Spatial Pyramid Pooling, and a weighted cross-entropy loss to counter class imbalance. Ten-fold cross-validation (60 epochs, batch size 8) was performed using the Adam optimizer (learning rate 1 × 10⁻⁴).</p><p><strong>Results: </strong>The proposed Deep Fusion Network (attention-enhanced DeepLabv3-ResNet101, Dfusion) model achieved a mean segmentation Dice coefficient of 0.8766 ± 0.012 and an intersection-over-union of 0.8052 ± 0.015. Classification results demonstrated an accuracy of 97.65%, precision of 88.26%, recall of 86.76%, and an F1-score of 85.33%. Receiver operating characteristic curve analysis yielded area under the curve values of 0.82 for superficial second-degree, 0.76 for deep second-degree, and 0.78 for third-degree burns. Compared with baseline DeepLabv3, FCN-ResNet101, U-Net-ResNet101, and MobileNet models, Dfusion improved Dice by 15.2%-19.7% and intersection-over-union by 14.9%-23.5% (all <i>p</i> < 0.01). Inference speed was 0.38 ± 0.03 s per image on an NVIDIA GTX 1060 GPU, highlighting the modest computational demands suitable for mobile deployment.</p><p><strong>Conclusion: </strong>Dfusion provides accurate, end-to-end segmentation and depth grading of pediatric burn wounds captured in uncontrolled environments. Its robust performance and modest computational demand support deployment on mobile devices, offering rapid, objective assistance for clinicians in resource-limited settings and enabling more precise triage and treatment planning for pediatric burn care.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"13 ","pages":"20503121251360090"},"PeriodicalIF":2.1,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12301600/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144733023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-24eCollection Date: 2025-01-01DOI: 10.1177/20503121251360120
Michael Effah Ntiamoah, Vivian Efua Senoo-Dogbey
<p><strong>Objective: </strong>This study sought to assess the health-related quality of life and its predictors among patients diagnosed with prostate cancer in two municipalities in the Volta Region of Ghana and to compare the scores between patients receiving treatment and those not receiving treatment.</p><p><strong>Methods: </strong>A cross-sectional hospital-based analytical study was conducted among 205 prostate cancer patients attending 2 hospitals in the Volta Region. Health-related quality of life was measured using the functional assessment of cancer therapy-prostate instrument, comprising subscales for physical, emotional, social and functional well-being. Group differences were assessed using Kruskal-Wallis <i>H</i> tests, and multiple linear regression was used to identify predictors of overall health-related quality of life.</p><p><strong>Results: </strong>The performance under the individual domains or subscales was 14.8 ± 8.7, 14.1 ± 5.6, 13.7 ± 6.6, 9.6 ± 7.7, and 20.1 ± 9.9 for the physical well-being, social/family well-being, emotional well-being, functional well-being and PC subscales, respectively. The functional assessment of cancer therapy-trial outcome index was 44.6 (standard deviation ±16.2). The Functional Assessment of Cancer Therapy-General (FACT-G) total score among the study participants was 52.2 (standard deviation ±15.5). The participants in this study had an overall functional assessment of cancer therapy-prostate total score of 72 (standard deviation ±22), an indication of a lower health-related quality of life performance. Contrary to expectations, untreated patients reported slightly better scores in physical and emotional well-being and higher overall health-related quality of life scores compared to those who received treatment. Emotional well-being was significantly lower among treated patients (mean = 12.6) compared to untreated patients (mean = 16.9). Treated patients showed marginally better social and functional well-being. While differences in total scores between the groups were not statistically significant (<i>p</i> = 0.27), clinical variables such as urinary incontinence, pain, anxiety, erectile dysfunction and bowel problems were significantly associated with lower quality of life (all <i>p</i> < 0.001). Regression analysis identified older age (β = -0.12, <i>p</i> = 0.03), erectile dysfunction (β = -0.47, <i>p</i> < 0.001), bowel problems (β = -0.19, <i>p</i> < 0.001) and anxiety (β = -0.18, <i>p</i> < 0.001) as independent predictors of poorer scores, whereas being married was associated with higher performance on the scale (β = 0.13, <i>p</i> = 0.01).</p><p><strong>Conclusion: </strong>The functional assessment of cancer therapy-prostate scale revealed notably low health-related quality of life scores among men with prostate cancer in the two municipalities of Ghana's Volta Region. Untreated patients reported better emotional and physical well-being, while treated patients had slightly better
目的:本研究旨在评估加纳Volta地区两个城市诊断为前列腺癌的患者的健康相关生活质量及其预测因素,并比较接受治疗和未接受治疗的患者之间的评分。方法:对在Volta地区2家医院就诊的205例前列腺癌患者进行横断面分析研究。与健康相关的生活质量使用癌症治疗功能评估-前列腺仪器进行测量,包括身体、情感、社会和功能健康的子量表。使用Kruskal-Wallis H检验评估组间差异,并使用多元线性回归确定总体健康相关生活质量的预测因子。结果:身体幸福感、社会/家庭幸福感、情绪幸福感、功能幸福感和个人幸福感在个体域或子量表上的得分分别为14.8±8.7、14.1±5.6、13.7±6.6、9.6±7.7和20.1±9.9。功能评估癌症治疗试验结局指数为44.6(标准差±16.2)。研究参与者的癌症治疗功能评估(FACT-G)总分为52.2(标准差±15.5)。本研究参与者的癌症治疗功能评估-前列腺总分为72(标准差±22),这表明与健康相关的生活质量表现较低。与预期相反,与接受治疗的患者相比,未经治疗的患者在身体和情绪健康方面的得分略高,总体健康相关生活质量得分也较高。与未治疗患者(平均= 16.9)相比,治疗患者的情绪幸福感显著降低(平均= 12.6)。接受治疗的患者表现出稍好的社交和功能幸福感。虽然两组之间的总分差异无统计学意义(p = 0.27),但尿失禁、疼痛、焦虑、勃起功能障碍和肠道问题等临床变量与生活质量下降(均p = 0.03)和勃起功能障碍(β = -0.47, p p p = 0.01)显著相关。结论:癌症治疗前列腺量表的功能评估显示,加纳Volta地区两个市前列腺癌患者的健康相关生活质量评分明显较低。未经治疗的患者报告有更好的情绪和身体健康,而接受治疗的患者有更好的社交和功能健康。未经治疗的患者总体得分更高。勃起功能障碍、肠道问题、焦虑和年龄的增长显著降低了测试成绩。婚姻积极地预示着更好的生活质量。临床或症状负担和心理社会因素对总体生活质量的影响大于治疗状况,强调需要全面护理。
{"title":"'Beyond Treatment': Clinical and psychosocial predictors of health-related quality of life of patients with prostate cancer.","authors":"Michael Effah Ntiamoah, Vivian Efua Senoo-Dogbey","doi":"10.1177/20503121251360120","DOIUrl":"10.1177/20503121251360120","url":null,"abstract":"<p><strong>Objective: </strong>This study sought to assess the health-related quality of life and its predictors among patients diagnosed with prostate cancer in two municipalities in the Volta Region of Ghana and to compare the scores between patients receiving treatment and those not receiving treatment.</p><p><strong>Methods: </strong>A cross-sectional hospital-based analytical study was conducted among 205 prostate cancer patients attending 2 hospitals in the Volta Region. Health-related quality of life was measured using the functional assessment of cancer therapy-prostate instrument, comprising subscales for physical, emotional, social and functional well-being. Group differences were assessed using Kruskal-Wallis <i>H</i> tests, and multiple linear regression was used to identify predictors of overall health-related quality of life.</p><p><strong>Results: </strong>The performance under the individual domains or subscales was 14.8 ± 8.7, 14.1 ± 5.6, 13.7 ± 6.6, 9.6 ± 7.7, and 20.1 ± 9.9 for the physical well-being, social/family well-being, emotional well-being, functional well-being and PC subscales, respectively. The functional assessment of cancer therapy-trial outcome index was 44.6 (standard deviation ±16.2). The Functional Assessment of Cancer Therapy-General (FACT-G) total score among the study participants was 52.2 (standard deviation ±15.5). The participants in this study had an overall functional assessment of cancer therapy-prostate total score of 72 (standard deviation ±22), an indication of a lower health-related quality of life performance. Contrary to expectations, untreated patients reported slightly better scores in physical and emotional well-being and higher overall health-related quality of life scores compared to those who received treatment. Emotional well-being was significantly lower among treated patients (mean = 12.6) compared to untreated patients (mean = 16.9). Treated patients showed marginally better social and functional well-being. While differences in total scores between the groups were not statistically significant (<i>p</i> = 0.27), clinical variables such as urinary incontinence, pain, anxiety, erectile dysfunction and bowel problems were significantly associated with lower quality of life (all <i>p</i> < 0.001). Regression analysis identified older age (β = -0.12, <i>p</i> = 0.03), erectile dysfunction (β = -0.47, <i>p</i> < 0.001), bowel problems (β = -0.19, <i>p</i> < 0.001) and anxiety (β = -0.18, <i>p</i> < 0.001) as independent predictors of poorer scores, whereas being married was associated with higher performance on the scale (β = 0.13, <i>p</i> = 0.01).</p><p><strong>Conclusion: </strong>The functional assessment of cancer therapy-prostate scale revealed notably low health-related quality of life scores among men with prostate cancer in the two municipalities of Ghana's Volta Region. Untreated patients reported better emotional and physical well-being, while treated patients had slightly better","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"13 ","pages":"20503121251360120"},"PeriodicalIF":2.1,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12301606/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144733020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-23eCollection Date: 2025-01-01DOI: 10.1177/20503121251330171
Anastasia V Poznyak, Nikolay A Orekhov, Alexey V Churov, Irina Alexandrovna Starodubtseva, Dmitry Felixovich Beloyartsev, Tatiana Ivanovna Kovyanova, Vasily N Sukhorukov, Alexander N Orekhov
Rheumatoid arthritis significantly increases the risk of cardiovascular disease due to chronic inflammation. This review's purpose is to critically analyze the intricate relationship between rheumatoid arthritis and cardiovascular disease, highlighting the mechanisms by which systemic inflammation contributes to cardiovascular risk and the effectiveness of current treatment strategies. We systematically evaluate existing literature on conventional cardiovascular risk factors in rheumatoid arthritis patients, as well as inflammation-specific markers that influence cardiovascular outcomes. Our conclusions indicate that while several treatment modalities, including methotrexate and other disease-modifying agents, may mitigate cardiovascular risk, there is a prevalent underestimation of true risk by standard cardiovascular disease assessment protocols. This review provides unique contributions by emphasizing the importance of integrating novel risk factors into assessment protocols and advocating for personalized management strategies that cater to the specific needs of rheumatoid arthritis patients. By synthesizing these elements, we aim to enhance understanding and guide clinicians in improving outcomes for rheumatoid arthritis patients at heightened risk of cardiovascular complications.
{"title":"Interplay of rheumatoid arthritis and cardiovascular disease: Insights and prospects.","authors":"Anastasia V Poznyak, Nikolay A Orekhov, Alexey V Churov, Irina Alexandrovna Starodubtseva, Dmitry Felixovich Beloyartsev, Tatiana Ivanovna Kovyanova, Vasily N Sukhorukov, Alexander N Orekhov","doi":"10.1177/20503121251330171","DOIUrl":"10.1177/20503121251330171","url":null,"abstract":"<p><p>Rheumatoid arthritis significantly increases the risk of cardiovascular disease due to chronic inflammation. This review's purpose is to critically analyze the intricate relationship between rheumatoid arthritis and cardiovascular disease, highlighting the mechanisms by which systemic inflammation contributes to cardiovascular risk and the effectiveness of current treatment strategies. We systematically evaluate existing literature on conventional cardiovascular risk factors in rheumatoid arthritis patients, as well as inflammation-specific markers that influence cardiovascular outcomes. Our conclusions indicate that while several treatment modalities, including methotrexate and other disease-modifying agents, may mitigate cardiovascular risk, there is a prevalent underestimation of true risk by standard cardiovascular disease assessment protocols. This review provides unique contributions by emphasizing the importance of integrating novel risk factors into assessment protocols and advocating for personalized management strategies that cater to the specific needs of rheumatoid arthritis patients. By synthesizing these elements, we aim to enhance understanding and guide clinicians in improving outcomes for rheumatoid arthritis patients at heightened risk of cardiovascular complications.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"13 ","pages":"20503121251330171"},"PeriodicalIF":2.1,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12290359/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144733022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-17eCollection Date: 2025-01-01DOI: 10.1177/20503121251356069
Mahsa Movahedan, Glen Brown
Objective: Intravenous solutions such as dextrose 5% in water and 0.9% sodium chloride (normal saline) differ in electrolyte composition from human plasma and may contribute to serum chloride derangements (dyschloremia). This retrospective study aimed to explore the relationship between fluid composition, particularly medication diluents, and dyschloremia development in the intensive care unit.
Methods: This was a retrospective chart review of adult intensive care unit patients with normal serum chloride on admission who developed dyschloremia after 48 h of intensive care unit admission. Data were collected on fluid types and volumes administered in the intensive care unit in the 7 days prior to dyschloremia onset. Descriptive statistics and chi-square tests were used to compare characteristics between patients who developed hyperchloremia and hypochloremia.
Results: Of 884 screened patients, 85 developed dyschloremia after 48 h (41 hypochloremia, 44 hyperchloremia). There was no significant association between the proportion of normal saline or dextrose 5% in water-containing fluids and the type of dyschloremia. However, dexmedetomidine, typically diluted in normal saline, was associated with hyperchloremia.
Conclusion: While total fluid composition was not associated with dyschloremia type, high-volume use of specific diluent-medication combinations may contribute. Strategies to minimize diluent volume could help reduce dyschloremia risk.
{"title":"Contribution of intravenous medication diluent fluid composition on the development of dyschloremia in intensive care unit patients: A retrospective chart review.","authors":"Mahsa Movahedan, Glen Brown","doi":"10.1177/20503121251356069","DOIUrl":"10.1177/20503121251356069","url":null,"abstract":"<p><strong>Objective: </strong>Intravenous solutions such as dextrose 5% in water and 0.9% sodium chloride (normal saline) differ in electrolyte composition from human plasma and may contribute to serum chloride derangements (dyschloremia). This retrospective study aimed to explore the relationship between fluid composition, particularly medication diluents, and dyschloremia development in the intensive care unit.</p><p><strong>Methods: </strong>This was a retrospective chart review of adult intensive care unit patients with normal serum chloride on admission who developed dyschloremia after 48 h of intensive care unit admission. Data were collected on fluid types and volumes administered in the intensive care unit in the 7 days prior to dyschloremia onset. Descriptive statistics and chi-square tests were used to compare characteristics between patients who developed hyperchloremia and hypochloremia.</p><p><strong>Results: </strong>Of 884 screened patients, 85 developed dyschloremia after 48 h (41 hypochloremia, 44 hyperchloremia). There was no significant association between the proportion of normal saline or dextrose 5% in water-containing fluids and the type of dyschloremia. However, dexmedetomidine, typically diluted in normal saline, was associated with hyperchloremia.</p><p><strong>Conclusion: </strong>While total fluid composition was not associated with dyschloremia type, high-volume use of specific diluent-medication combinations may contribute. Strategies to minimize diluent volume could help reduce dyschloremia risk.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"13 ","pages":"20503121251356069"},"PeriodicalIF":2.3,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12276513/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144675599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-17eCollection Date: 2025-01-01DOI: 10.1177/20503121251355442
Ding Ding, Yi Jiang, Yajing Lin, Ting Zhang, Jiejie Guo, Tian Jiang, Linyao Huang, Jianxin Yan, Long He
Purpose: This study aimed to investigate the pathogenic characteristics of Vibrio parahaemolyticus in Taizhou City, China, to provide a scientific basis for the diagnosis and control of Vibrio parahaemolyticus in the region.
Methods: Bacterial strains were isolated from stool specimens of diarrheal patients at the First People's Hospital of Wenling City. The virulence genes, serotypes, and antibiotic susceptibility of these strains were determined.
Results: From June 1, 2020 to May 31, 2023, a total of 97 strains of Vibrio parahaemolyticus were isolated from stool specimens of diarrheal patients at the First People's Hospital of Wenling City. The results of virulence gene detection showed that 87.6% of the strains were thermostable direct hemolysin (TDH; tdh)+, thermolabile hemolysin (tlh)+, and tdh-related hemolysin (trh)-, 11.3% were tdh-tlh+trh-, and 1.0% were tdh+tlh+trh+. Six different serotypes were identified, with O3:K4 and O4:K4 being the most common, accounting for 42.3% and 32.0%, respectively. The other serotypes identified were O3:K6, O4:K8, and O1:KUT, accounting for 11.3%, 10.3%, and 3.1%, respectively. Furthermore, the results of antimicrobial susceptibility tests showed that most strains were sensitive to the tested drugs, while some strains exhibited resistance to cefuroxime (32.6%) and cefazolin (43.6%).
Conclusion: The majority of the isolated Vibrio parahaemolyticus strains carried the tdh gene, and the O3:K4 serotype dominated in Taizhou City from 2020 to 2023, followed by the O4:K4 serotype. Furthermore, some strains exhibited resistance to cefuroxime and cefazolin.
目的:了解泰州市副溶血性弧菌的病原学特点,为该地区副溶血性弧菌的诊断和控制提供科学依据。方法:从温岭市第一人民医院腹泻患者粪便标本中分离菌株。测定了这些菌株的毒力基因、血清型和抗生素敏感性。结果:2020年6月1日至2023年5月31日,从温岭市第一人民医院腹泻患者粪便标本中共分离出副溶血性弧菌97株。毒力基因检测结果显示,87.6%的菌株为耐热型直接溶血素(TDH);Tdh)+、耐热溶血素(tlh)+、Tdh相关溶血素(trh)-,其中Tdh - tlh + trh -占11.3%,Tdh + tlh + trh +占1.0%。共鉴定出6种不同的血清型,其中以O3:K4和O4:K4最为常见,分别占42.3%和32.0%。其他血清型分别为O3:K6、O4:K8和O1:KUT,分别占11.3%、10.3%和3.1%。药敏试验结果显示,大多数菌株对试验药物敏感,部分菌株对头孢呋辛(32.6%)和头孢唑林(43.6%)耐药。结论:台州市2020 - 2023年分离到的副溶血性弧菌大部分携带tdh基因,且以O3:K4血清型为主,其次为O4:K4血清型。此外,一些菌株对头孢呋辛和头孢唑林表现出耐药性。
{"title":"Characterization of <i>Vibrio parahaemolyticus</i> isolated from stool specimens of diarrhea patients in Taizhou, China during 2020-2023.","authors":"Ding Ding, Yi Jiang, Yajing Lin, Ting Zhang, Jiejie Guo, Tian Jiang, Linyao Huang, Jianxin Yan, Long He","doi":"10.1177/20503121251355442","DOIUrl":"10.1177/20503121251355442","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to investigate the pathogenic characteristics of <i>Vibrio parahaemolyticus</i> in Taizhou City, China, to provide a scientific basis for the diagnosis and control of <i>Vibrio parahaemolyticus</i> in the region.</p><p><strong>Methods: </strong>Bacterial strains were isolated from stool specimens of diarrheal patients at the First People's Hospital of Wenling City. The virulence genes, serotypes, and antibiotic susceptibility of these strains were determined.</p><p><strong>Results: </strong>From June 1, 2020 to May 31, 2023, a total of 97 strains of <i>Vibrio parahaemolyticus</i> were isolated from stool specimens of diarrheal patients at the First People's Hospital of Wenling City. The results of virulence gene detection showed that 87.6% of the strains were thermostable direct hemolysin (TDH; <i>tdh</i>)<sup>+</sup>, thermolabile hemolysin (<i>tlh</i>)<sup>+</sup>, and <i>tdh</i>-related hemolysin (<i>trh</i>)<sup>-</sup>, 11.3% were <i>tdh</i> <sup>-</sup> <i>tlh</i> <sup>+</sup> <i>trh</i> <sup>-</sup>, and 1.0% were <i>tdh</i> <sup>+</sup> <i>tlh</i> <sup>+</sup> <i>trh</i> <sup>+</sup>. Six different serotypes were identified, with O3:K4 and O4:K4 being the most common, accounting for 42.3% and 32.0%, respectively. The other serotypes identified were O3:K6, O4:K8, and O1:KUT, accounting for 11.3%, 10.3%, and 3.1%, respectively. Furthermore, the results of antimicrobial susceptibility tests showed that most strains were sensitive to the tested drugs, while some strains exhibited resistance to cefuroxime (32.6%) and cefazolin (43.6%).</p><p><strong>Conclusion: </strong>The majority of the isolated <i>Vibrio parahaemolyticus</i> strains carried the <i>tdh</i> gene, and the O3:K4 serotype dominated in Taizhou City from 2020 to 2023, followed by the O4:K4 serotype. Furthermore, some strains exhibited resistance to cefuroxime and cefazolin.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"13 ","pages":"20503121251355442"},"PeriodicalIF":2.3,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12276508/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144675579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}